Status:

COMPLETED

Evaluate the Effort Test as a Therapeutic Monitoring Tool in Acute Rhabdomyolyses

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

URC-CIC Paris Descartes Necker Cochin

Conditions:

Rhabdomyolysis Linked to a Hereditary Disease of Metabolism

Eligibility:

All Genders

6-75 years

Brief Summary

The prognosis of rhabdomyolyses related to hereditary diseases of metabolism is poor and treatments are only symptomatic. Rhabdomyolysis outbreaks are frequently precipitated by fever and fasting. The...

Detailed Description

Rhabdomyolysis is a poorly known symptom associated with the destruction of skeletal muscle cells. The diagnosis of rhabdomyolyses is carried when the dosage of muscle enzymes, in particular creatine ...

Eligibility Criteria

Inclusion

  • subjects with metabolic rhabdomyolysis related to a hereditary metabolic disease :
  • Inclusion Criteria:
  • pathology characterized on the biochemical and molecular level
  • patients who can make an effort test
  • patients who benefited from a diagnostically targeted muscle biopsy with backup of myoblasts (group 1)
  • patients who have benefited from a diagnostically targeted muscle biopsy but whose myoblasts are not available (group 2) Exclusion Criteria
  • inability or refusal of compliance to the requirements of the research
  • patients with contraindications for the effort test in particular heart failure and acute rhabdomyolysis
  • Patients without biochemical and/or molecular diagnosis
  • Criteria for inclusion of witness patients :
  • holders of parental authority and/or patients not opposed to the use of their cardio-respiratory analysis results for this study or to the use of their myoblasts for this study
  • normal cardio-respiratory analysis results
  • normal myoblasts (group 4).

Exclusion

    Key Trial Info

    Start Date :

    October 25 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2021

    Estimated Enrollment :

    27 Patients enrolled

    Trial Details

    Trial ID

    NCT03802279

    Start Date

    October 25 2019

    End Date

    December 31 2021

    Last Update

    September 12 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hôpital Necker-Enfants Malades

    Paris, France, 75015